Bulletin from extraordinary shareholders’ meeting of Calliditas Therapeutics AB (publ) December 14, 2018 16:15 CET Regulatory Read more
Notice of extraordinary shareholders’ meeting of Calliditas Therapeutics AB (publ) November 14, 2018 08:00 CET Regulatory Read more
First patient enrolled in pivotal clinical phase 3 study NEFIGARD with lead candidate Nefecon November 13, 2018 16:20 CET Regulatory Read more
Calliditas Therapeutics’ nomination committee for the AGM 2019 October 4, 2018 10:00 CET Regulatory Read more
Exercise of over-allotment option and end of the stabilization period July 29, 2018 18:30 CET Regulatory Read more
Calliditas announces listing on Nasdaq Stockholm and related prospectus June 15, 2018 05:00 CET Regulatory Read more
